Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Holding GB:AGY?
Track your performance easily

Allergy Therapeutics (AGY) Share Price & Analysis

12 Followers

AGY Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.10%0.12%99.78%
0.12% Other Institutional Investors
99.78% Public Companies and
Individual Investors

AGY FAQ

What was Allergy Therapeutics PLC’s price range in the past 12 months?
Allergy Therapeutics PLC lowest share price was 1.40p and its highest was 6.30p in the past 12 months.
    What is Allergy Therapeutics PLC’s market cap?
    Currently, no data Available
    When is Allergy Therapeutics PLC’s upcoming earnings report date?
    Allergy Therapeutics PLC’s upcoming earnings report date is Mar 05, 2025 which is in 117 days.
      How were Allergy Therapeutics PLC’s earnings last quarter?
      Allergy Therapeutics PLC released its earnings results on Nov 06, 2024. The company reported -0.005p earnings per share for the quarter, the consensus estimate of -0.005p by 0p.
        Is Allergy Therapeutics PLC overvalued?
        According to Wall Street analysts Allergy Therapeutics PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Allergy Therapeutics PLC pay dividends?
          Allergy Therapeutics PLC does not currently pay dividends.
          What is Allergy Therapeutics PLC’s EPS estimate?
          Allergy Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Allergy Therapeutics PLC have?
          Allergy Therapeutics PLC has 4,766,440,000 shares outstanding.
            What happened to Allergy Therapeutics PLC’s price movement after its last earnings report?
            Allergy Therapeutics PLC reported an EPS of -0.005p in its last earnings report, expectations of -0.005p. Following the earnings report the stock price went up 1.476%.
              Which hedge fund is a major shareholder of Allergy Therapeutics PLC?
              Currently, no hedge funds are holding shares in GB:AGY
              ---

              Allergy Therapeutics Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              297.16%
              12-Months-Change

              Fundamentals

              Return on Equity
              -1392.76%
              Trailing 12-Months
              Asset Growth
              -2.91%
              Trailing 12-Months

              Company Description

              Allergy Therapeutics PLC

              Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Advanced Medical Solutions
              Benchmark Holdings
              Creo Medical
              EKF Diagnostics Holdings
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis